DE69737456D1 - Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen - Google Patents

Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen

Info

Publication number
DE69737456D1
DE69737456D1 DE69737456T DE69737456T DE69737456D1 DE 69737456 D1 DE69737456 D1 DE 69737456D1 DE 69737456 T DE69737456 T DE 69737456T DE 69737456 T DE69737456 T DE 69737456T DE 69737456 D1 DE69737456 D1 DE 69737456D1
Authority
DE
Germany
Prior art keywords
protein
lait
cells
activation
immunotropic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69737456T
Other languages
English (en)
Other versions
DE69737456T2 (de
Inventor
Michael H Julius
Dominik Filipp
Kamel Alizadeh-Khiavi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arthritis and Autoimmunity Research Centre Foundation AARC
Original Assignee
Arthritis and Autoimmunity Research Centre Foundation AARC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arthritis and Autoimmunity Research Centre Foundation AARC filed Critical Arthritis and Autoimmunity Research Centre Foundation AARC
Publication of DE69737456D1 publication Critical patent/DE69737456D1/de
Application granted granted Critical
Publication of DE69737456T2 publication Critical patent/DE69737456T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69737456T 1996-11-18 1997-11-18 Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen Expired - Lifetime DE69737456T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/746,883 US6093693A (en) 1996-11-18 1996-11-18 B cell activation
US746883 1996-11-18
PCT/CA1997/000880 WO1998022580A2 (en) 1996-11-18 1997-11-18 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation

Publications (2)

Publication Number Publication Date
DE69737456D1 true DE69737456D1 (de) 2007-04-19
DE69737456T2 DE69737456T2 (de) 2007-11-29

Family

ID=25002765

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69737456T Expired - Lifetime DE69737456T2 (de) 1996-11-18 1997-11-18 Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen

Country Status (16)

Country Link
US (4) US6093693A (de)
EP (2) EP0941322B1 (de)
JP (1) JP4447058B2 (de)
CN (1) CN100516215C (de)
AT (1) ATE356205T1 (de)
AU (1) AU732476B2 (de)
BR (1) BR9713096A (de)
CA (1) CA2272051C (de)
CZ (1) CZ300752B6 (de)
DE (1) DE69737456T2 (de)
DK (1) DK0941322T3 (de)
ES (1) ES2284183T3 (de)
HU (1) HU226217B1 (de)
IL (1) IL129855A (de)
PL (1) PL193670B1 (de)
WO (1) WO1998022580A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0101987A3 (en) * 1998-05-27 2010-01-28 Gemma Biotechnology Ltd The induction of antibiotic peptides by lait (scd14) protein
WO2000022945A2 (en) * 1998-10-20 2000-04-27 Societe Des Produits Nestle S.A. Protein for treatment or prevention of a gastrointestinal tract disorder
EP1111388A1 (de) * 1999-12-23 2001-06-27 Universiteit Gent Interaktion zwischen CD14 und HBV-Komponenten
US6984503B1 (en) * 2002-06-27 2006-01-10 The United States Of America As Represented By The Secretary Of The Agriculture Use of recombinant bovine CD14 in the treatment and prevention of coliform mastitis in dairy cows
WO2004081038A1 (en) * 2003-03-11 2004-09-23 Regen Therapeutics Plc Purification of peptides from colostrum
ES2232273B1 (es) * 2003-03-21 2006-07-16 Jose Manuel Fernandez-Real Lemos Nuevas aplicaciones terapeuticas de la glucoproteina cd14s.
US20060134190A1 (en) * 2004-12-16 2006-06-22 Banner Pharmacaps Inc. Formulations of bisphosphonate drugs with improved bioavailability

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543303A (en) * 1988-11-28 1996-08-06 Goyert; Sanna M. Recombinant myelomonocytic differentiation antigen CD14
ES2120948T3 (es) * 1989-08-01 1998-11-16 Scripps Research Inst Procedimiento y composiciones que mejoran los sintomas de la sepsis.
EP0634935A4 (de) 1992-04-06 1996-01-31 North Shore Univ Hospital Eine neuartige therapie des sepsis mittels einer löslichen form des rekombinanten cd14 myelomonocytischen antigens.
AU695124B2 (en) * 1993-05-28 1998-08-06 Scripps Research Institute, The Methods and compositions for inhibiting CD14 mediated cell activation
US5932536A (en) 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
US5766593A (en) * 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
EP0793677A1 (de) * 1994-12-30 1997-09-10 Amgen Inc. Entzündungshemmende cd14 polypeptide
AU5688596A (en) * 1995-04-13 1996-10-30 Deutsche Om Arzneimittel Gmbh Anti-cd14 antibodies for use in the induction of il-10 secre tion
US6168787B1 (en) * 1995-04-24 2001-01-02 John Wayne Cancer Institute Pluripotent vaccine against enveloped viruses
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
EP0941322B1 (de) 2007-03-07
PL193670B1 (pl) 2007-03-30
PL333413A1 (en) 1999-12-06
IL129855A (en) 2013-06-27
CA2272051C (en) 2012-09-18
HU226217B1 (en) 2008-06-30
BR9713096A (pt) 2000-10-24
CZ300752B6 (cs) 2009-08-05
JP2001504695A (ja) 2001-04-10
IL129855A0 (en) 2000-02-29
EP1801216A2 (de) 2007-06-27
EP0941322A2 (de) 1999-09-15
HUP0001057A2 (hu) 2000-08-28
ATE356205T1 (de) 2007-03-15
WO1998022580A2 (en) 1998-05-28
US20070014809A1 (en) 2007-01-18
CZ175199A3 (cs) 1999-11-17
DE69737456T2 (de) 2007-11-29
US6093693A (en) 2000-07-25
JP4447058B2 (ja) 2010-04-07
CA2272051A1 (en) 1998-05-28
EP1801216A3 (de) 2007-11-07
DK0941322T3 (da) 2007-06-25
CN100516215C (zh) 2009-07-22
US20040258704A1 (en) 2004-12-23
HUP0001057A3 (en) 2002-09-30
ES2284183T3 (es) 2007-11-01
US6676985B1 (en) 2004-01-13
WO1998022580A3 (en) 1998-10-01
CN1238010A (zh) 1999-12-08
AU5045198A (en) 1998-06-10
AU732476B2 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
CA2266859C (en) Colostrinin, and uses thereof
EP0210189A4 (de) Rekombinantes alveolares oberflächenaktives protein.
IL85411A0 (en) Methods and deoxyribonucleic acid for the preparation of tissue factor protein
Schijns et al. Immunoadjuvant activities of E. coli-and plasmid-expressed recombinant chicken IFN-α/β, IFN-γ and IL-1β in 1-day-and 3-week-old chickens
GB9224584D0 (en) Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
KR900701824A (ko) 동물 감염의 치료 또는 예방을 위한 조성물 및 그 방법
CN100503829C (zh) 白细胞介素-18突变体、其制品及应用
ZA943465B (en) Transforming growth factor alpha H1
IL82364A (en) Recombinant expression system for producing alveolar surfactant protein (asp) encoded by human sp-18, human sp-5 or canine sp-5 dna; recombinant asp produced thereby and pharmaceutical compositions containing the recombinant asp
DE69737456D1 (de) Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen
EP0294469A4 (de) Impfstoffe und diagnosetest für haemophilus influenzae.
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
EP0770137A4 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
JPS6455143A (en) Production of milk powder for nursing which is endowed with phylactic ability
BR0012740A (pt) Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
EP1027071A2 (de) Eingekapselte immunmodulatoren als impfstoffadjuvantien
AU9514701A (en) Colostrinin, and uses thereof
MXPA99003108A (en) Colostrinin, and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition